Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
Farmers Insurance
Dow
Mallinckrodt
UBS
Teva
Johnson and Johnson
Deloitte

Generated: April 26, 2018

DrugPatentWatch Database Preview

LOTRIMIN ULTRA Drug Profile

« Back to Dashboard

When do Lotrimin Ultra patents expire, and what generic alternatives are available?

Lotrimin Ultra is a drug marketed by Bayer Healthcare Llc and is included in one NDA.

The generic ingredient in LOTRIMIN ULTRA is butenafine hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Drug patent expirations by year for LOTRIMIN ULTRA
Synonyms for LOTRIMIN ULTRA
(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanaminium chloride
1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthalenylmethyl)methanamine hydrochloride
1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthylmethyl)methanamine hydrochloride
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine hydrochloride
101827-46-7
4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine hydrochloride
827B467
A800463
A800464
AB0106850
AB07686
AC-2116
AC1L9FCX
AKOS015895328
AN-14303
ANW-42439
API0001792
BC205781
BCP9000464
BG0596
Butenafine (Hydrochloride)
Butenafine HCL
Butenafine hydrochloide
Butenafine hydrochloride
Butenafine hydrochloride (JP17/USAN)
Butenafine hydrochloride [USAN:JAN]
Butenafine hydrochloride, >=98% (HPLC)
BUTOP
C12490
CAS-101827-46-7
CC-25280
CCG-220604
CHEBI:31325
CHEMBL1200397
CS-1124
CTK8B3383
D01093
DSSTox_CID_28515
DSSTox_GSID_48589
DSSTox_RID_82787
DTXSID2048589
FT-0631017
FT-0699734
HY-17396
I06-0721
J-000499
K-0256
KP-363
KS-00000FUA
KS-1035
LJBSAUIFGPSHCN-UHFFFAOYSA-N
Mentax
Mentax (TN)
MLS003899213
MolPort-005-934-229
N-((4-(1,1-Dimethylethyl)phenyl)methyl)-N-methyl-1-naphthalenemethanamine hydrochloride
N-(4-(tert-butyl)benzyl)-N-methyl-1-(naphthalen-1-yl)methanamine hydrochloride
N-(4-t-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride;N-(4-t-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride
N-(4-TERT-BUTYLBENZYL)-N-METHYL-1-NAPHTHALENEMETHYLAMINE HYDROCHLORIDE
N-(4-tert-butylbenzyl)-N-methyl-1-naphthylmethylamine hydrochloride
N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride
N-[[4-(1,1-Dimethylethyl)phenyl]methyl]-N-methyl-1-naphthalenemethanamine hydrochloride
N-4-t-butylbenzyl-N-methyl-1-naphthalenemethylamine hydrochloride
N-4-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine hydrochloride
R8XA2029ZI
RTR-000443
s3154
SC-17334
SCHEMBL262301
Scorba
SMR002204106
ST51052828
SureCN1648813
Tox21_112918
TR-000443
UNII-R8XA2029ZI
Volley
Volley (TN)

US Patents and Regulatory Information for LOTRIMIN ULTRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc LOTRIMIN ULTRA butenafine hydrochloride CREAM;TOPICAL 021307-001 Dec 7, 2001 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
AstraZeneca
Medtronic
Baxter
Teva
Cantor Fitzgerald
Dow
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.